Table 2

Characteristics of study population at follow-up in relation to tertiles (T1–T3) of c-f PWV (n = 2,450)

Whole study populationT1T2T3P value
n2,450808831811
c-f PWV* (m/s)9.93 (8.67–11.53)8.17 (7.57–8.65)9.93 (9.47–10.37)12.30 (11.53–13.90)
Age (years)71.92 (±5.55)69.43 (±4.92)71.72 (±5.32)74.59 (±5.17)<0.001
Heart rate (bpm)62.57 (±9.80)60.29 (±9.12)62.64 (±9.86)64.77 (±9.90)<0.001
MAP (mmHg)95.68 (±10.58)91.09 (±9.47)96.15 (±9.63)99.78 (±10.76)<0.001
Waist (cm)90.40 (±11.66)88.11 (±11.17)90.49 (±11.64)92.59 (±11.75)<0.001
Smokers, n (%)241 (9.8)93 (11.5)87 (10.5)61 (7.5)0.020
Use of antihypertensive drugs, n (%)1,200 (49)323 (40)411 (49.5)466 (57.5)<0.001
FPG (mmol/L)5.73 (±0.61)5.66 (±0.63)5.72 (±0.59)5.81 (±0.61)<0.001
2-h post-OGTT plasma glucose (mmol/L) (n = 2,424)6.73 (±1.92)6.30 (±1.82)6.71 (±1.87)7.19 (±1.99)<0.001
LDL cholesterol (mmol/L)3.43 (±0.90)3.51 (±0.91)3.41 (±0.88)3.38 (±0.91)0.008
HDL cholesterol (mmol/L)1.47 (±0.44)1.50 (±0.43)1.47 (±0.44)1.43 (±0.43)0.002
Triglycerides* (mmol/L) (n = 2,448)0.90 (0.70–1.20)0.90 (0.70–1.10)0.90 (0.70–1.30)1.00 (0.80–1.30)<0.001
FH+ father, n (%)183 (7.5)52 (6.4)68 (8.2)63 (7.8)0.374
FH+ mother, n (%)237 (9.7)77 (9.5)84 (10.1)76 (9.4)0.868
  • Values expressed are means (±SD) unless specified otherwise.

  • *Median (25–75%). FH+, family history–positive.